AbbVie Inc. · Q1 2026
ReportedMay 1, 2026
Period endedMar 31, 2026
Rule of 40+36
The quarter in short
Revenue $15.00B, up 12.4% year over year and down 9.7% on the quarter. EPS $0.39, down 45.8% year over year and 61.8% on the quarter. Free cash flow $3.56B, up 154.6% year over year and down 27.1% on the quarter. Rule of 40 score +36.
Reported this quarter
Revenue
$15.00B
QoQ −9.7%
YoY +12.4%
EPS
$0.39
QoQ −61.8%
YoY −45.8%
Free Cash Flow
$3.56B
QoQ −27.1%
YoY +154.6%
Gross Margin
71.9%
QoQ −0.7 pp
YoY +1.9 pp
FCF Margin
23.8%
QoQ −5.7 pp
YoY +13.3 pp
P/E Ratio
107.1
QoQ +10.7%
YoY +24.2%
Each tile opens the full quarterly series. Download the numbers as CSV or JSON.
Sources & downloads
Company
Published by the company on the day of the release.
HTML
Earnings press release
Investor relations announcement
SEC filings
Filed with the SEC under CIK 1551152.
HTML
8-K results announcement
Filed Apr 29, 2026
HTM
Press release (EX-99.1)
Exhibit 99.1 to the 8-K
223 KB
HTML
Filing index
Every document in the 8-K submission
TXT
Complete submission
Raw archival text of the whole filing
HTML
10-Q quarterly report
Period ended Mar 31, 2026, filed May 8, 2026
ZIP
XBRL data bundle
Structured financial statements from the 10-Q
JSON
Company facts (XBRL)
Every figure ABBV has reported to the SEC
R40 data
The numbers shown on this page, as we hold them.
CSV
This quarter (CSV)
Reported metrics for Q1 2026, spreadsheet-ready
JSON
This quarter (JSON)
Metrics, dates and matched filings